MedAvail Holdings Overview
Valuation check: MDVL's ROE is -201.69%, below the Consumer Discretionary sector average of 23.23%.
Get informed when a big investor buys or sells
+ Follow-201.69%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for MDVL is -201.69%. That is below the Consumer Discretionary sector average of 23.23%. Investors often review this figure alongside MedAvail Holdings's historical trend and sector peers before judging valuation or financial health.
Against Consumer Discretionary companies, MDVL currently prints -201.69% for ROE, while the sector average sits near 23.23%. That is roughly 968.3% below the sector mean. Large gaps often invite a closer look at MedAvail Holdings's growth, margins, and balance sheet.
Return on Equity shows how effectively MedAvail Holdings converts resources into returns. At -201.69%, MDVL may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MDVL's ROE (-201.69%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack MedAvail Holdings's ROE against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.
